The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based Study.

health care utilization hospitalizations inflammatory bowel disease mental health physician visits population based

Journal

Inflammatory bowel diseases
ISSN: 1536-4844
Titre abrégé: Inflamm Bowel Dis
Pays: England
ID NLM: 9508162

Informations de publication

Date de publication:
19 08 2021
Historique:
received: 01 08 2020
pubmed: 5 12 2020
medline: 10 2 2022
entrez: 4 12 2020
Statut: ppublish

Résumé

Inflammatory bowel disease (IBD) is associated with an increase in psychiatric comorbidity (PC) compared with the general population. We aimed to determine the impact of PC on health care utilization in persons with IBD. We applied a validated administrative definition of IBD to identify all Manitobans with IBD from April 1, 2006, to March 31, 2016, and a matched cohort without IBD. A validated definition for PC in IBD population was applied to both cohorts; active PC status meant ≥2 visits for psychiatric diagnoses within a given year. We examined the association of active PC with physician visits, inpatient hospital days, proportion with inpatient hospitalization, and use of prescription IBD medications in the following year. We tested for the presence of a 2-way interaction between cohort and PC status. Our study matched 8459 persons with IBD to 40,375 controls. On crude analysis, IBD subjects had ≥3.7 additional physician visits, had >1.5 extra hospital days, and used 2.1 more drug types annually than controls. Subjects with active PC had >10 more physician visits, had 3.1 more hospital days, and used >6.3 more drugs. There was a synergistic effect of IBD (vs no IBD) and PC (vs no PC) across psychiatric disorders of around 4%. This synergistic effect was greatest for anxiety (6% [2%, 9%]). After excluding psychiatry-related visits and psychiatry-related hospital stays, there remained an excess health care utilization in persons with IBD and PC. Inflammatory bowel disease with PC increases health care utilization compared with matched controls and compared with persons with IBD without PC. Active PC further increases health care utilization.

Sections du résumé

BACKGROUND
Inflammatory bowel disease (IBD) is associated with an increase in psychiatric comorbidity (PC) compared with the general population. We aimed to determine the impact of PC on health care utilization in persons with IBD.
METHODS
We applied a validated administrative definition of IBD to identify all Manitobans with IBD from April 1, 2006, to March 31, 2016, and a matched cohort without IBD. A validated definition for PC in IBD population was applied to both cohorts; active PC status meant ≥2 visits for psychiatric diagnoses within a given year. We examined the association of active PC with physician visits, inpatient hospital days, proportion with inpatient hospitalization, and use of prescription IBD medications in the following year. We tested for the presence of a 2-way interaction between cohort and PC status.
RESULTS
Our study matched 8459 persons with IBD to 40,375 controls. On crude analysis, IBD subjects had ≥3.7 additional physician visits, had >1.5 extra hospital days, and used 2.1 more drug types annually than controls. Subjects with active PC had >10 more physician visits, had 3.1 more hospital days, and used >6.3 more drugs. There was a synergistic effect of IBD (vs no IBD) and PC (vs no PC) across psychiatric disorders of around 4%. This synergistic effect was greatest for anxiety (6% [2%, 9%]). After excluding psychiatry-related visits and psychiatry-related hospital stays, there remained an excess health care utilization in persons with IBD and PC.
CONCLUSION
Inflammatory bowel disease with PC increases health care utilization compared with matched controls and compared with persons with IBD without PC. Active PC further increases health care utilization.

Identifiants

pubmed: 33274369
pii: 6020061
doi: 10.1093/ibd/izaa310
pmc: PMC8376123
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1462-1474

Subventions

Organisme : CIHR
ID : THC-135234
Pays : Canada

Informations de copyright

© 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Clin Gastroenterol Hepatol. 2011 Sep;9(9):769-75
pubmed: 21645640
Inflamm Bowel Dis. 2013 Jun;19(7):1528-33
pubmed: 23518810
Gen Hosp Psychiatry. 2018 Mar - Apr;51:71-78
pubmed: 29353127
Aging Ment Health. 2016;20(6):627-36
pubmed: 25897560
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S73-S80
pubmed: 31294387
Adv Ther. 2015 Nov;32(11):983-1028
pubmed: 26547912
Annu Rev Psychol. 2011;62:583-619
pubmed: 19575624
Dig Dis Sci. 2017 Dec;62(12):3563-3567
pubmed: 29052816
Clin Gastroenterol Hepatol. 2015 Jul;13(7):1302-1309.e3
pubmed: 25638585
J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):658-664
pubmed: 27035372
Inflamm Bowel Dis. 2016 Sep;22(9):2127-33
pubmed: 27482980
PLoS One. 2018 Mar 13;13(3):e0194029
pubmed: 29534097
Am J Gastroenterol. 2007 Aug;102(8):1683-91
pubmed: 17459026
J Psychosom Res. 2017 Oct;101:17-23
pubmed: 28867419
Clin Gastroenterol Hepatol. 2017 Mar;15(3):385-392.e2
pubmed: 27645518
Can J Public Health. 2012 Jul 04;103(8 Suppl 2):S23-7
pubmed: 23618067
Neurology. 2014 Sep 2;83(10):929-37
pubmed: 25085638
Inflamm Bowel Dis. 2021 Jan 1;27(1):40-48
pubmed: 32095835
Can J Psychiatry. 2005 Jun;50(7):398-406
pubmed: 16086537
Inflamm Bowel Dis. 2016 Mar;22(3):752-62
pubmed: 26841224
J Psychosom Res. 2016 Oct;89:107-13
pubmed: 27663119
Clin Gastroenterol Hepatol. 2017 Jul;15(7):986-997
pubmed: 28300693
Inflamm Bowel Dis. 2019 Jun 18;25(7):1255-1261
pubmed: 30615113
Am J Epidemiol. 1999 May 15;149(10):916-24
pubmed: 10342800
Inflamm Bowel Dis. 2019 Jan 10;25(2):360-368
pubmed: 29986021
Inflamm Bowel Dis. 2019 Sep 18;25(10):1674-1680
pubmed: 30888037
Inflamm Bowel Dis. 2011 Jun;17(6):1270-6
pubmed: 21560190
Inflamm Bowel Dis. 2016 Jun;22(6):1442-9
pubmed: 26950309
BMC Res Notes. 2017 Nov 25;10(1):619
pubmed: 29178935
Inflamm Bowel Dis. 2018 Oct 12;24(11):2303-2308
pubmed: 29788469
Inflamm Bowel Dis. 2017 Sep;23(9):1568-1576
pubmed: 28700534
Am J Gastroenterol. 2008 Aug;103(8):1989-97
pubmed: 18796096
Inflamm Bowel Dis. 2019 Sep 18;25(10):1718-1728
pubmed: 31211836
J Crohns Colitis. 2019 May 27;13(6):744-754
pubmed: 30916775
Clin Gastroenterol Hepatol. 2006 Jun;4(6):731-43
pubmed: 16631415
Arthritis Care Res (Hoboken). 2021 Jan;73(1):90-99
pubmed: 32702203
J Pediatr Psychol. 2012 Apr;37(3):282-91
pubmed: 22080456

Auteurs

Charles N Bernstein (CN)

Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Carol A Hitchon (CA)

Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Randy Walld (R)

Manitoba Centre for Health Policy, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

James M Bolton (JM)

Department of Psychiatry, Max Rady College of Medicine Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Lisa M Lix (LM)

Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Renée El-Gabalawy (R)

Department of Clinical Health Psychology, Max Rady College of Medicine Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Departments of Anesthesiology, Perioperative and Pain Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Jitender Sareen (J)

Department of Psychiatry, Max Rady College of Medicine Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Alexander Singer (A)

Department Family Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Alan Katz (A)

Manitoba Centre for Health Policy, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Department Family Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

James Marriott (J)

Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

John D Fisk (JD)

Nova Scotia Health Authority, Departments of Psychiatry, Psychology & Neuroscience, and Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

Scott B Patten (SB)

Departments of Community Health Sciences & Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Ruth Ann Marrie (RA)

Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH